Fluor

FLR · NYSE

$45.18−$1.39 (−2.98%)TodayMarket closed ·
Prev close $46.57

FLR analyst rating

BuyConsensus of 6 analysts over the last 12 months. 67% rate it a buy.
  • Strong buy0
  • Buy4
  • Hold2
  • Underperform0
  • Sell0

12-month price target · 9 analysts

Average $59.81 (+32.4% upside)

Low
$46.46
Now
$45.18
High
$71.40

Upgrades and downgrades

The latest rating actions, newest first

FLR analyst upgrades, downgrades and rating actions
FirmDateActionRating
UBSAug 10, 2026MaintainsBuy
Truist SecuritiesAug 10, 2026MaintainsBuy
CitigroupAug 10, 2026MaintainsBuy
BairdAug 10, 2026MaintainsNeutral
BarclaysAug 10, 2026MaintainsEqual-Weight
Truist SecuritiesJul 2, 2026MaintainsBuy
Truist SecuritiesMay 11, 2026MaintainsBuy
CitigroupMay 11, 2026MaintainsBuy
BairdMay 11, 2026MaintainsNeutral
CitigroupFeb 20, 2026MaintainsBuy

The case for and against

Updated Oct 21, 2026

Bull case

Fluor is supported by a more diversified earnings base across urban, mission, and energy solutions, with secular growth exposure in data centers, life sciences, mining, nuclear, and power that should help drive double-digit earnings growth over the medium term with less concentration risk. The company also posted $15.5 billion in 2025 revenue and has a large, high-quality backlog that is about 85% cost reimbursable, while recent awards of $6.1 billion and a pipeline above $60 billion point to sustained bookings momentum and improving visibility. Despite some one-time project noise, its strong cash position of $3.0 billion, ongoing $1.4 billion share repurchase authorization, and shrinking legacy problem projects leave investors focused on a cleaner operating profile and a stronger free cash flow trajectory.

Bear case

Fluor is facing a mixed fundamental backdrop where strong 2Q’26 execution was offset by a still-elevated dependence on project wins and a backlog that fell 5% y/y to $26.891B, with Energy Solutions backlog down 38% y/y to $3.461B. Although revenue rose 9% y/y to $4.329B and adjusted EPS of $0.91 beat estimates, the quarter included about $0.23 of charges tied to Gordie Howe, underscoring persistent project-execution risk and volatility in earnings quality. The company’s awards momentum and book-to-burn of 1.4x are encouraging, but with about 85% of backlog cost reimbursable and management still citing macro, supply-chain, regulatory, and labor risks, upside in profitability remains constrained.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.